Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 1;58(2):221.
doi: 10.3390/medicina58020221.

Renal Cell Carcinoma or Oncocytoma? The Contribution of Diffusion-Weighted Magnetic Resonance Imaging to the Differential Diagnosis of Renal Masses

Melike Metin  1 , Hasan Aydın  2 , Mustafa Karaoğlanoğlu  3
Affiliations

Renal Cell Carcinoma or Oncocytoma? The Contribution of Diffusion-Weighted Magnetic Resonance Imaging to the Differential Diagnosis of Renal Masses

Melike Metin et al. Medicina (Kaunas). .

Abstract

Background and Objectives: Renal Cell Carcinoma (RCC) accounts for 85% and oncocytomas constitute 3-7% of solid renal masses. Oncocytomas can be confused, especially with hypovascular RCC. The purpose of this research was to evaluate the contribution of diffusion-weighted imaging (DWI) and contrast-enhanced MRI sequences in the differential diagnosis of RCC and oncocytoma Materials and Methods: 465 patients with the diagnosis of RCC and 45 patients diagnosed with oncocytoma were retrospectively reviewed between 2009 to 2020. All MRI acquisitions were handled by a 1.5 T device (Achieva, Philips Healthcare, Best, The Netherlands) and all images were evaluated by the consensus of two radiologists with 10-15 years' experience. The SPSS package program version 15.0 software was used for statistical analysis of the study. Chi-square test, Mann-Whitney U test or the Kruskal-Wallis tests were used in the statistical analysis. A receiver operating characteristic (ROC) curve was used to calculate the cut-off values Results: The results were evaluated with a 95% confidence interval and a significance threshold of p < 0.05. ADC values (p < 0.001) and enhancement index (p < 0.01) were significantly lower in the RCC group than the oncocytoma group. Conclusion: DWI might become an alternative technique to the contrast-enhanced MRI in patients with contrast agent nephropathy or with a high risk of nephrogenic systemic fibrosis, calculation of CI of the oncocytoma and RCCs in the contrast-enhanced acquisitions would contribute to the differential diagnosis.

Keywords: ADC; DWI; carcinoma; cell; oncocytoma; renal.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
ROC curve of the ADC values for the differentiation of RCC and oncocytoma separation.
Figure 2
Figure 2
ROC curve of the combined ADC value and CI for the differentiation of RCC and oncocytoma.
Figure 3
Figure 3
(a) Renal mass (RCC) in the lower pole of right kidney, low enhancing proportional to the renal cortex but very dark with low ADC and (b) concrete restricted diffusion in diffusion-weighted imaging (DWI).
Figure 3
Figure 3
(a) Renal mass (RCC) in the lower pole of right kidney, low enhancing proportional to the renal cortex but very dark with low ADC and (b) concrete restricted diffusion in diffusion-weighted imaging (DWI).
Figure 4
Figure 4
(a) Oncocytoma in the the lower pole of left kidney, (b) iso-mild hyperintense in T2W images with obvious restricted diffusion and (c) hyperintense in DWI.
Figure 4
Figure 4
(a) Oncocytoma in the the lower pole of left kidney, (b) iso-mild hyperintense in T2W images with obvious restricted diffusion and (c) hyperintense in DWI.
Figure 5
Figure 5
(a) Renal mass lesion (RCC) in the upper pole of right kidney, (b) hyperintense in T2W images with high contrast enhancing.
Figure 6
Figure 6
(a) Oncocytoma in the upper pole of left kidney, (b) iso-hyperintense in T2W images with high diffusion restriction and (c) moderate contrast enhancing.
Figure 6
Figure 6
(a) Oncocytoma in the upper pole of left kidney, (b) iso-hyperintense in T2W images with high diffusion restriction and (c) moderate contrast enhancing.
See this image and copyright information in PMC

References

    1. Mytsyk Y., Dutka I., Borys Y., Komnatska I., Shatynska-Mytsyk I., Farooqi A.A., Gazdikova K., Caprida M., Rodrigo L., Kruzliak P. Renal cell carcinoma: Applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade. Int. Urol. Nephrol. 2017;49:215–224. doi: 10.1007/s11255-016-1460-3. - DOI - PubMed
    1. Yu X., Lin M., Ouyang H., Zhou C., Zhang H. Application of ADC measurement in characterization of renal cell carcinomas with different pathological types and grades by 3.0 T diffusion-weighted MRI. Eur. J. Radiol. 2012;81:3061–3066. doi: 10.1016/j.ejrad.2012.04.028. - DOI - PubMed
    1. Lassel E., Rao R., Schwenke C., Schoenberg S., Michaely H. Diffusion-weighted imaging of focal renal lesions: A meta-analysis. Eur. Radiol. 2014;24:241–249. doi: 10.1007/s00330-013-3004-x. - DOI - PubMed
    1. Perez-Ordonez B., Hamed G., Campbell S., Erlandson R.A., Russo P., Gaudin P.B., Reuter V.E. Renal oncocytoma: A clinicopathologic study of 70 cases. Am. J. Surg. Pathol. 1997;21:871–883. doi: 10.1097/00000478-199708000-00001. - DOI - PubMed
    1. Gakis G., Kramer U., Schilling D., Kruck S., Stenzl A., Schlemmer H.P. Small renal oncocytomas: Differentiation with multiphase CT. Eur. J. Radiol. 2011;80:274–278. doi: 10.1016/j.ejrad.2010.06.049. - DOI - PubMed

MeSH terms